Background
Methods
Baseline characteristics
Covariate | Mean ± SD or Number (%) |
---|---|
Demographics | |
Age, years | 69 ± 9 |
Male sex | 27 (68) |
New York Heart Association class III/IV | 3 (8) |
Comorbidities | |
Systemic hypertension | 23 (58) |
Diabetes mellitus | 6 (15) |
Chronic obstructive pulmonary disease | 3 (8) |
Chronic kidney disease | 15 (38) |
Cerebrovascular events | 2 (5) |
Echocardiography
Surgical technique
Follow-up
Statistical analyses
Results
Echocardiographic outcomes
Preoperative data | Follow-up data | P value | |
---|---|---|---|
LA dimension (mm) | 60 ± 11 | 54 ± 13 | <.001* |
LV end-diastolic dimension (mm) | 55 ± 7 | 51 ± 8 | <.001* |
LV end-systolic dimension (mm) | 37 ± 7 | 36 ± 9 | 0.30 |
Ejection fraction (%) | 60 ± 11 | 57 ± 15 | 0.13 |
Moderate or severe MR | 40 | 5 | |
Moderate or severe TR | 22 | 3 |
Recurrent MR (+) | Recurrent MR (−) | P value | |
---|---|---|---|
LA dimension (mm) | 71 ± 12 | 59 ± 9 | 0.008* |
LV end-diastolic dimension (mm) | 64 ± 3 | 54 ± 1 | 0.001* |
LV end-systolic dimension (mm) | 43 ± 3 | 36 ± 1 | 0.034* |
Ejection fraction (%) | 60 ± 5 | 60 ± 2 | 0.91 |
Perioperative data
Covariate | Mean ± SD or Number (%) |
---|---|
Median annuloplasty ring size (range) | 28 (24–34) mm |
Mitral valve procedures | |
Mitral ring annuloplasty only | 19 (48) |
Anterior mitral leaflet neochordoplasty | 19 (48) |
Posterior mitral leaflet augmentation | 3 (8) |
Basal chordae resection | 2 (5) |
Concomitant procedures | |
Maze procedures | 20 (50) |
Tricuspid ring annuloplasty | 31 (78) |
Left atrial plication | 9 (23) |
Cardiopulmonary bypass time | 177 ± 38 min |
Cross-clamp time | 134 ± 31 min |
Clinical outcomes
Covariate | Mean ± SD or Number (%) |
---|---|
Early outcomes | |
In-hospital mortality | 0 |
Acute renal failure requiring hemodialysis | 2 (5) |
Re-exploration for bleeding | 1 (3) |
Cerebrovascular events | 1 (3) |
Deep sternal wound infection | 0 |
Midterm outcomes | |
Patient deaths during the follow-up period | 7 (18) |
Cardiac death | 4 (10) |
Recurrent moderate or severe MR | 5 (13) |
Re-admission for heart failure | 7 (18) |
Cerebrovascular events | 1 (3) |
Reoperation for recurrent MR | 2 (5) |
Permanent pacemaker implantation | 6 (15) |
Systemic embolism | 1 (3) |